Year: 2023

Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives

Written by Customer Service on November 20, 2023. Posted in Public Companies.

BURLINGTON, Mass. and JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Blue Cross Blue Shield of Louisiana (BCBS of LA) has joined the growing list of payors reducing the patient eligibility requirements for transcranial magnetic stimulation (TMS) treatment from four failed medication trials to two. BCBS of LA’s recent policy update aligns with the growing body of scientific evidence supporting the use of Deep TMS earlier in the treatment journey and underscores the insurer’s commitment to ensuring that patients have timely access to cutting-edge therapies. With 1.9 million covered lives, BCBS of LA provides coverage for more than 40% of Louisiana’s...

SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors

Written by Customer Service on November 20, 2023. Posted in Public Companies.

SIOUX FALLS, S.D., Nov. 20, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Katie Ellias has been appointed to the Company’s Board of Directors. With Ms. Ellias’ appointment, the SAB Biotherapeutics Board is composed of ten directors, eight of whom are independent. Ms. Ellias serves as a Managing Director at the JDRF T1D Fund LLC, a venture philanthropy fund with approximately $200 million in assets, including an investment in SAB. Ms. Ellias joined the T1D Fund in 2018 where she has led a number of investments in companies developing T1D-oriented therapies. She has also served as a director...

Hammerhead Energy Inc. Announces Filing of Management Information Circular for Special Meeting of Shareholders

Written by Customer Service on November 20, 2023. Posted in Public Companies.

CALGARY, Alberta, Nov. 20, 2023 (GLOBE NEWSWIRE) — Hammerhead Energy Inc. (“Hammerhead” or the “Company”) (TSX: HHRS; NASDAQ: HHRS) is pleased to announce that it has filed the management information circular (“Information Circular”) and related meeting materials (together with the Information Circular, the “Meeting Materials”) for the special meeting of holders (“Shareholders”) of Class A common shares of Hammerhead (“Hammerhead Shares”) to be held at 2400, 525 – 8th Avenue S.W., Calgary, Alberta, T2P 1G1 on December 20, 2023 at 8:30 a.m. (Calgary time) (the “Meeting”). At the Meeting, Shareholders will be asked to consider, and, if thought advisable, approve a Plan of Arrangement (the “Arrangement”) pursuant to which, among other things,...

American Shared Hospital Services Enters Into Agreement to Acquire 60% Majority Interest in Three Radiation Therapy Cancer Centers in Rhode Island

Written by Customer Service on November 20, 2023. Posted in Public Companies.

– Accretive Transaction to Expand U.S. Footprint – SAN FRANCISCO, CA, Nov. 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — American Shared Hospital Services (NYSE American: AMS) (“ASHS” or the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced that it has entered into an Investment Purchase Agreement (the “IPA”) to purchase a 60% majority equity interest in the Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, both Rhode Island limited liability companies (collectively, the “Target Companies”), as well as certain payor contracts, from GenesisCare USA, Inc., a Florida corporation (the “Seller”), for a purchase price of $2.85 million....

Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company

Written by Customer Service on November 20, 2023. Posted in Mergers And Acquisitions.

Acquisition includes OLPRUVA®, an FDA-approved treatment for urea cycle disorders (UCDs), which propels Zevra into commercial stage, diversifying its revenue and providing scale Settlement of Acer’s warrant obligations through direct transaction with a healthcare focused investment fund adds quality healthcare investor to Zevra’s shareholder base CELEBRATION, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the completion of its acquisition of Acer Therapeutics Inc. (Acer) which marks a significant step forward in executing Zevra’s strategy to become a leader in developing and commercializing treatments for rare diseases and furthers the Company’s commitment to supporting patient communities with limited or no existing therapeutic...

Fleets Facing Need to Improve Crew Morale and Wellbeing Turn to KVH for Content Services

Written by Customer Service on November 20, 2023. Posted in Public Companies.

KVH Link’s news from home, movies and TV programming, social activities, and sports offer fleet and crewing managers an easy means of supporting crew welfare MIDDLETOWN, R.I., Nov. 20, 2023 (GLOBE NEWSWIRE) — Recognizing the need to keep crew connected to home, family, and popular culture, innovative fleets such as TMS Gas Cardiff of the UK, Nereus Shipping SA in Greece, Tomini Transports LLC in Dubai, and GFS Fleet Management in Dubai have turned to KVH Industries, Inc. (Nasdaq: KVHI) for content services designed to enhance crew well-being. Content options range from daily local news to blockbuster films, popular TV programming, real-time sports statistics, music, and social engagement through karaoke and other content. “It’s vital to remember that commercial vessels aren’t simply floating offices and warehouses but homes for...

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

Written by Customer Service on November 20, 2023. Posted in Public Companies.

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced a partnership with Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, to use Medidata AI Intelligent Trials to increase access to diverse patients in clinical trials conducted by Fortrea. Fortrea’s use of Medidata AI builds on an existing collaboration between the two companies, expanding on Fortrea’s use of Medidata Rave EDC, an advanced, robust, and secure EDC system for clinical trial site, patient and lab data capture and management. Fortrea will leverage features of Medidata AI Intelligent Trials,...

Virtu Financial Congratulates Women in Finance Award Recipients Ashley Kryshtalsky and Kathryn Novak

Written by Customer Service on November 20, 2023. Posted in Public Companies.

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT) a leading provider of financial services and products that leverage cutting-edge technology to deliver innovative, transparent trading solutions to our clients and liquidity to the global markets, is pleased to congratulate Ashley Kryshtalsky and Kathryn Novak for being recognized at Markets Media’s Women in Finance Awards. These prestigious awards recognize women who have made a significant contribution to the financial industry with their entrepreneurial spirit and leadership. Ashley Kryshtalsky, based in New York, plays an integral role on Virtu’s Workflow Technology team with a focus on Virtu’s Triton Execution Management System (EMS). Extremely astute and client-oriented, Ashley has been pivotal in helping Virtu’s Triton EMS become the top ranked...

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

Written by Customer Service on November 20, 2023. Posted in Public Companies.

BELTSVILLE, Md., Nov. 20, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the 35th Annual Piper Sandler Healthcare Conference in New York City on Thursday, November 30th, at 1:30 pm ET. A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available after the event and archived on the website for 30 days. About NextCure, Inc.NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases....

OTC Markets Group Welcomes d’Amico International Shipping SA to OTCQX

Written by Customer Service on November 20, 2023. Posted in Public Companies.

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced d’Amico International Shipping SA (Euronext STAR Milan: DIS; OTCQX: DMCOF), an international marine transportation company operating in the product tanker market, has qualified to trade on the OTCQX® Best Market. d’Amico International Shipping upgraded to OTCQX from the Pink® market. d’Amico International Shipping SA begins trading today on OTCQX under the symbol “DMCOF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals